Reductive metabolism of 1-nitropyrene accompanies deamination of cytosine

S A Malia1, A K Basu

  • 1Department of Chemistry, University of Connecticut, Storrs 06269.

Insights

Reductive metabolism of 1-nitropyrene (1-NP) generates DNA adducts, leading to mutations like C-to-T transitions. This process, involving cytosine deamination, is crucial for understanding 1-NP

Area of Science:

  • Environmental Health
  • Molecular Toxicology
  • Carcinogenesis

Background:

  • 1-Nitropyrene (1-NP) is an environmental pollutant known for its mutagenic and tumorigenic properties.
  • Nitroreduction is a primary metabolic activation pathway for 1-NP.
  • Understanding the specific mutations caused by activated 1-NP is critical for assessing its health risks.

Purpose of the Study:

  • To investigate the mutational specificity of reductively activated 1-nitropyrene.
  • To identify the major DNA adducts formed and the types of mutations induced.
  • To elucidate the role of cytosine deamination in the mutagenic mechanism.

Main Methods:

  • Treatment of single-stranded M13mp18 DNA with tritium-labeled 1-nitrosopyrene and ascorbic acid to generate N-hydroxy-1-aminopyrene.
  • High-performance liquid chromatography (HPLC) analysis of enzymatically digested DNA to identify tritium-labeled adducts.
  • Transfection of adducted M13 DNA into Escherichia coli to assess viability and mutagenesis.
  • Mutation analysis, particularly C-->T transitions, in the lacZ gene fragment.

Main Results:

  • A major DNA adduct, N-(deoxyguanosin-8-yl)-1-aminopyrene, was identified, accounting for over 95% of tritium incorporation.
  • Transfection of adducted DNA resulted in a dose-dependent decrease in bacterial viability and increased mutagenesis.
  • The predominant mutation observed in the absence of SOS functions was C-->T transition (48%).
  • Ascorbic acid-induced nitroreduction was found to cause significant cytosine deamination, explaining the C-->T transitions.

Conclusions:

  • Reductive activation of 1-nitropyrene leads to the formation of specific DNA adducts that are mutagenic.
  • Cytosine deamination during nitroreduction is a key mechanism responsible for C-->T transitions induced by 1-NP metabolites.
  • Mammalian nitroreductases like xanthine oxidase can catalyze this deamination process, highlighting potential in vivo relevance.

Related Concept Videos

Preparation of Amines: Reduction of Oximes and Nitro Compounds01:29

Preparation of Amines: Reduction of Oximes and Nitro Compounds

Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Preparation of Amines: Reductive Amination of Aldehydes and Ketones01:38

Preparation of Amines: Reductive Amination of Aldehydes and Ketones

Carbonyl compounds and primary amines undergo reductive amination first to produce imines, followed by secondary amines in the same reaction mixture, using selective reducing agents like sodium cyanoborohydride or sodium triacetoxyborohydride. Reductive amination produces different degrees of substitution of amines depending on the starting amine substrate.
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems01:15

Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
Inorganic Nitrogen Assimilation01:22

Inorganic Nitrogen Assimilation

Nitrogen is an essential element in biological systems, forming a crucial component of proteins, nucleic acids, and other cellular constituents. Many bacteria and archaea acquire nitrogen in the form of nitrate (NO₃⁻) or ammonia (NH₃), which are then assimilated into biomolecules through specific enzymatic pathways.Assimilatory Nitrate ReductionWhen nitrate enters the cell, it undergoes a two-step reduction process known as assimilatory nitrate reduction. Initially, the enzyme nitrate reductase...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...